Global X China MedTech ETF(02841.HK) surged by over 2% in the afternoon, ranking first among stock ETFs! OpenAI enters the health sector
In terms of news, on January 8, 2026, OpenAI launched the ChatGPT Health function, which can answer health questions, connect smart devices, and plan diet and exercise, with functions similar to "Ant Afu". This model is integrated into ChatGPT and is claimed to be "an independent space specifically for health-related conversations with ChatGPT", and is expected to be gradually opened to users in the coming weeks.
On the trading front, Wind data shows that as of 14:15 on January 9, 2026,Global X China MedTech ETF(02841.HK) rose significantly after the afternoon opening, with an increase of 2.27%. Its constituent stock Meinian Health hit the daily limit.
New Time and Space Research Institute pointed out that medical and health, as one of the most promising application scenarios for AI technology, is becoming a strategic highland that domestic and foreign technology giants are competing to layout. Compared with other AI application scenarios, the medical and health field has the characteristics of strong rigid demand, high data value, and clear policy support. Especially against the backdrop of accelerating population aging and increasing residents' health awareness, the commercialization path of AI-enabled medical services is becoming increasingly clear.
Global X China MedTech ETF(02841.HK) is an exchange-traded fund (ETF) that tracks China's medical technology industry. It aims to reflect the overall performance of the industry by investing in Chinese medical technology companies listed globally, covering subdivisions such as innovative drugs, medical devices, and medical services.
New Time and Space Research Institute suggests that this product is suitable for investors who pay attention to the long-term growth potential of China's medical technology industry and seek to diversify their investment portfolios, especially medium and long-term investors who have an in-depth understanding of innovative drug research and development, localization of medical devices, and medical service demand driven by aging, and can withstand higher volatility.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
